作者: John G.F. Cleland , James McGowan
DOI: 10.1097/00005344-199906003-00003
关键词: Digoxin 、 Myocardial infarction 、 Ischemia 、 Intensive care medicine 、 Heart failure 、 Vascular disease 、 Surgery 、 Heart disease 、 Epidemiology 、 Amlodipine 、 Medicine 、 Pharmacology 、 Cardiology and Cardiovascular Medicine
摘要: Ischaemic heart disease is the most common underlying cause of failure in industrialised countries. Its manifestations are protean with myocardial infarction being only one important facet. The prognosis patients due to ischaemic also appears be worse than that associated many other aetiologies. presence may influence both efficacy and choice treatment. Agents such as digoxin amlodipine appear less effective while ACE inhibitors beta-blockers or more disease. Many have expressed an opinion about how coronary should managed patient supported by little no evidence. There major theoretical practical concerns use anti-coagulant, anti-platelet statin therapy well benefits. Only randomised controlled trials will resolve these issues. same said revascularisation. Fortunately addressing all areas under way. This put management on a firm evidence-based footing.